Monday, September 26, 2022

Comments by Sunbelt Wellness Institute

Showing 4 of 4 comments.

  • Ms. Spencer,
    I believe my original message may have been misconstrued. The study is linked below the article and specifically says Esketamine (Not Ketamine). The author of this article then wrote in Ketamine where the original authors had Esketamine. That is not silencing. This author has blatantly edited the original findings and replaced each mention of Esketamine with Ketamine. As we stated above these are not the same medication. Enantiomers have massive effects on drug delivery and targeting. I do not believe the author did this on purpose but possibly thought they were the same substance. Misinformation is damaging to persons seeking treatment. We are hoping to bring light to this so that education/research/ethics are again at the forefront of medical literature and commentary.

    Thank you

  • Good Morning Mr. Simmons,

    At multiple points throughout your article you state Ketamine was tested or that Ketamine was approved by the FDA. The BMJ article clearly states that this was Esketamine which had the outcomes similar to placebo. While you may think that enantiomers would have similar effects, they do not. Take the drug which is constantly harped on for its differences of effect when using the Left or Right handed version, Thalidomide. One version helps with nausea during pregnancy, the other causes children to be born without limbs. Enantiomeric effects are important to understand, and comparing Racemic Ketamine with the left-handed enantiomer Esketamine is being intellectually dishonest. Stigma in mental health and emerging therapies is already difficult enough to manage. Please do not contribute to the issue. I believe you may have just been mistaken. I hope a swift correction or clarification is made.